Hui Peng
Hui Peng
1
Department of Cell Biology and Genetics, Key Laboratory of Molecular Biology in High Cancer Incidence Coastal Chao Shan Area of Guang Dong Higher Education Institutes, Shantou University Medical College, Shantou, China
2
Department of Clinical Laboratory, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
1,2,†,
Juping Wang
Juping Wang
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
3,†,
Xuhong Song
Xuhong Song
1
Department of Cell Biology and Genetics, Key Laboratory of Molecular Biology in High Cancer Incidence Coastal Chao Shan Area of Guang Dong Higher Education Institutes, Shantou University Medical College, Shantou, China
1,
Jiangni Huang
Jiangni Huang
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
3,
Haoming Hua
Haoming Hua
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
3,
Fanlu Wang
Fanlu Wang
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
3,
Ziyun Xu
Ziyun Xu
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
3,
Jing Ma
Jing Ma
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
3,
Jie Gao
Jie Gao
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
3,
Jing Zhao
Jing Zhao
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
3,
Anna Nong
Anna Nong
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
3,
Dongyang Huang
Dongyang Huang
1
Department of Cell Biology and Genetics, Key Laboratory of Molecular Biology in High Cancer Incidence Coastal Chao Shan Area of Guang Dong Higher Education Institutes, Shantou University Medical College, Shantou, China
1,*,†,
Bin Liang
Bin Liang
1
Department of Cell Biology and Genetics, Key Laboratory of Molecular Biology in High Cancer Incidence Coastal Chao Shan Area of Guang Dong Higher Education Institutes, Shantou University Medical College, Shantou, China
1,*,†
1
Department of Cell Biology and Genetics, Key Laboratory of Molecular Biology in High Cancer Incidence Coastal Chao Shan Area of Guang Dong Higher Education Institutes, Shantou University Medical College, Shantou, China
2
Department of Clinical Laboratory, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
3
Department of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China
Edited and reviewed by: Janos G. Filep, Université de Montréal, Canada
✉*Correspondence: Bin Liang, bliang@stu.edu.cn; Dongyang Huang, huangdy@stu.edu.cn
†These authors have contributed equally to this work
This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology
Received 2022 Feb 23; Accepted 2022 Mar 1; Collection date 2022.
Keywords: PHLDA1, TLR4, suppress, proinflammatory cytokine, Tollip
Copyright © 2022 Peng, Wang, Song, Huang, Hua, Wang, Xu, Ma, Gao, Zhao, Nong, Huang and Liang
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.